Alimera Sciences fulfills unmet eye-care needs
October 15th 2005Alpharetta, GA—When the global management of Novartis decided to shut down its ophthalmic operations in Duluth, GA, in early 2003 and relocate to New Jersey, Dan Myers, then president of Novartis Ophthalmics/North America, thought he would leave the company and have the next 6 months to relax.
Read More
Intravitreal triamcinolone helps macular diseases
October 1st 2005Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.
Read More
Be a good doctor-win valuable prizes!
August 15th 2005Do you remember when you applied to medical school because you thought it would be a great way to help your fellow human beings, and when being a good physician was its own reward? Times have changed, and now doing your utmost to help your patients is not just a sacred trust, but a way to get paid better!
Read More
NEI spearheads nanomedicine initiative
August 15th 2005Fort Lauderdale, FL—Nanomedicine—the application of technology that uses minute devices to treat disease—is a primary component of the National Institutes of Health (NIH) "Roadmap for New Pathways to Discovery" that was introduced in 2002 by Elias Zerhouni, MD, director of the NIH.
Read More
Age-related maculopathy: a product of genetics and environment?
July 15th 2005Fort Lauderdale, FL—The phenotype of age-related macular disease provides information about the genes that confer risk or the environmental factors that are involved in risk in a particular individual, according to Alan Bird, MD, who spoke at the annual meeting of the Association for Research in Vision and Ophthalmology.
Read More
How to get your group practice on the same page
May 1st 2005For some ophthalmologists, group practices offer many benefits over solo practices. But often, one of the biggest challenges is managing physicians' different personalities and styles, especially when it comes to making decisions for the good of the group.
Read More
Don't lose your home in a lawsuit... or waste the equity
April 1st 2005As the authors of Wealth Protection, MD and as advisors to numerous physician clients, we are constantly amazed at how few physicians have actually taken the necessary steps to shield their homes from lawsuits. Doctors pay millions in dollars over their careers for medical malpractice insurance coverage and often thousands more to protect some of their assets, yet they still fail to protect their single largest asset. Why is this?
Read More